Ella Therapeutics
Ella Therapeutics

Ella Therapeutics

DR0Ahrefs DR: 0/100. Bottom 25%. Measured by Ahrefs. Median 44.Agent21Agent Readiness: 21/100. Bottom 25%. Measured by StartupHub.ai. Median 41.Speed96Site Speed: 96/100. Top 25%. Measured by Google PageSpeed. Median 62.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Website
2019Active4Boston, United States

About

Ella Therapeutics is a biotechnology company focused on developing novel microbiome-derived therapies to address resistance to immune checkpoint inhibitors (ICIs) in cancer treatment. Their research utilizes a unique Reverse Clinical Development method to identify and characterize specific microbial agents that can enhance the efficacy of existing cancer immunotherapies.

Key facts

At-a-glance profile data

Website
ellatherapeutics.com
Headquarters
Boston, United States
Founded
2019
Employees
4
Total funding
-
Business model
B2B

Tech stack

Detected on ellatherapeutics.com, last scanned 22 Aug 2026. Run your own scan

Email provider
Google Workspace
Add first review

Frequently asked

How many employees does Ella Therapeutics have?

Ella Therapeutics has approximately 4 people on record.